References
- Shaikh N. A., Abidi S. E., Block L. H. Drug Dev. Ind. Pharm. 1987; 13(8)1345–1369
- Sohroeder H. G., Dakkuri A., Deluca P. P. J. Pharm, Sci. 1978; 67: 350–353
- Buriet P., Doelker E. Pharm. Acta Helv. 1978; 55(Nr 7–8)189–197
- Cameron C. G., McGinity J. W. Drug Dev. Ind. Pharm. 1987; 13(8)U09–U27
- Georgakopoulos P. P., Georgarakis M., Führer C. Acta Pharm. Technol. 1981; 27(4)231–236
- United States Patent. 4,215,104. to Med Johnson and Company, Evansville, Ind.
- U.S.P. XX2th rev. United States Pharmacopoeia Convention, Inc., Washington 1980
- Weddle O. H., Mason W. D. J. Pharm. Sci. 1976; 65(6)865
- Schnack J. A., Waxier S. H. J. Pharmacol. Exp. Ther. 1949; 97: 283
- Shah V. P., Riegelman S. J. Pharm. Sci. 1974; 63: 1283
- Cohen J. L., Carrettson L. K. Acad, of Pharm. Sci. Annual Meeting. Nov., 1974
- Thompson R. D., et al. J. Lab. Clin. Med. 1974; 84: 584
- Jonkman G., et al. Pharm. Weekblad 1980; 2: 557
- Brown R. D., Manno J. E. J. Pharm. Sci. 1978; 67(12)1687
- Shargel L., Yu A. B.C. Applied Biopharmaceutics and Pharmacokinetics2nd edition. Appleton-Century-Crofts, Norwalk, ConnecticutUSA 1985; 229–252
- Greek Pharmacopoeia, III3rd Edition. 1974; 1214
- Chester E., et al. Curr, Ther. Res. 1982; 32(3)476
- Van der Vet A. P.H., et al. Int. J. Clin. Pharm. Ther. Toxicol. 1984; 22(8)423
- Hendeles L., Iafrate R. P., Weinberger M. Clin. Pharmacokinetics 1984; 9: 95
- Ogilvie R. I. Clin. Pharmacokinetics 1978; 3: 267